Mekanisme Gangguan Kardiovaskular pada COVID-19
DOI:
https://doi.org/10.55175/cdk.v48i1.33Kata Kunci:
COVID-19, kardiovaskularAbstrak
Keterlibatan jantung lazim terjadi dan menjadi suatu tanda prognostik buruk pada COVID-19; myocard infarct (MCI) dan gagal jantung berkontribusi pada 40% kematian pasien COVID-19. Mekanisme kerusakan organ jantung belum diteliti lebih lanjut, mungkin karena peningkatan kerja jantung akibat kondisi gagal napas dan hipoksemia yang dipicu oleh infeksi COVID-19, adanya infeksi miokard langsung oleh SARS-CoV-2, respons inflamasi sistemik, atau kombinasi tiga faktor tersebut.
Cardiac involvement is common and a poor prognostic factor for COVID-19; myocardial infarction (MCI) and heart failure contribute to 40% death in COVID-19 patients. The mechanism has not been studied thoroughly; this damage may be due to increased heart workload associated with respiratory failure and hypoxemia triggered by COVID-19 infection, direct myocardial infection by SARS-CoV-2, systemic inflammatory response, or a combination of these three factors.
Unduhan
Referensi
Alemzadeh-Ansari M. Coronavirus disease 2019 (COVID-19) and cardiovascular events. Res Cardiovasc Med. 2020;9(1):1.
Shi S. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol [Internet]. 2020. Available from: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85082439582&origin=inward
Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol.2020;5(7):811–8.
4. Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID ‑ 19 based on an analysis of data of 150 patients from Wuhan , China. Intensive Care Med [Internet]. 2020. Available from: https://doi.org/10.1007/s00134-020-05991-x
Babapoor-farrokhran S, Gill D, Walker J, Rasekhi RT. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID- 19. The COVID-19 resource centre is hosted on Elsevier Connect, the company ’ s public news and information. 2020;14:185-9.
Zhou P, Yang X Lou, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature [Internet]. 2020;579(7798):270–3. Available from: http://dx.doi.org/10.1038/s41586-020-2012-7
Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579(7798):265–9.
Vagner D, Frumence É, Ah-pine F. Deciphering SARS-CoV-2 virologic and immunologic features. 2020;21(16):5932.
Maier HJ, Bickerton E, Britton P. Coronaviruses: Methods and protocols. Coronaviruses Methods Protoc. 2015;1282(1):1–282.
Dijkman R, Jebbink MF, Deijs M, Milewska A, Pyrc K, Buelow E, et al. Replication-dependent downregulation of cellular angiotensin-converting enzyme 2 protein expression by human coronavirus NL63. J Gen Virol. 2012;93(PART 9):1924–9.
Tikellis C, Thomas MC. Angiotensin-converting enzyme 2 (ACE2) is a key modulator of the renin angiotensin system in health and disease. Int J Pept. 2012;2012:256294.
Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet 2020;395:470–3.
Crackower MA, Sarao R, Oliveira-dos-Santos AJ, Da Costa J, Zhang L. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature. 2002;417(6891):822–8.
Akhmerov A, Marbán E. COVID-19 and the heart. Circ Res. 2020;126:1443–55.
Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–20.
Kaye R, Chang CWD, Kazahaya K, Brereton J, Denneny JC. COVID-19 anosmia reporting tool: Initial findings. Otolaryngol - Head Neck Surg (United States). 2020;163(1):132–4.
Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, et al. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: Estimation and application. Ann Intern Med. 2020;172(9):577–82.
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet [Internet]. 2020;395(10229):1054–62. Available from: http://dx.doi.org/10.1016/S0140-6736(20)30566-3
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 Novel coronavirus-infected pneumonia in Wuhan, China. JAMA - J Am Med Assoc. 2020;323(11):1061–9.
Inciardi RM, Lupi L, Zaccone G, Italia L, Raffo M, Tomasoni D, et al. Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19). JAMA Cardiol.2020;5(7):819–24.
Estabragh ZR, Mamas MA. The cardiovascular manifestations of influenza: A systematic review. Int J Cardiol [Internet]. 2013;167(6):2397–403. Available from: http://dx.doi.org/10.1016/j.ijcard.2013.01.274
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China:A descriptive study. Lancet [Internet]. 2020;395(10223):507–13. Available from: http://dx.doi.org/10.1016/S0140-6736(20)30211-7
Luo W, Yu H, Gou J, Li X, Sun Y, Li J, et al. Clinical pathology of critical patient with novel coronavirus pneumonia (COVID-19). Preprints [Internet]. 2020:2020020407. Available from: https://www.researchgate.net/publication/339939319
Moores LK, Tritschler T, Brosnahan S, Carrier M, Collen JF, Doerschug K, et al. Prevention, diagnosis, and treatment of VTE in patients with coronavirus disease 2019:CHEST guideline and expert panel report. Chest [Internet]. 2020;158(3):1143–63. Available from: https://doi.org/10.1016/j.chest.2020.05.559
Lindner D, Fitzek A, Bräuninger H, Aleshcheva G, Edler C, Meissner K, et al. Association of cardiac infection with SARS-CoV-2 in confirmed COVID-19 autopsy cases.JAMA Cardiol. 2020;5(11):1281-5.
Oudit GY, Kassiri Z, Jiang C, Liu PP, Poutanen SM, Penninger JM, et al. SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. Eur J Clin Invest. 2009;39(7):618–25.
Hamming I, Timens W, Bulthuis MLC, Lely AT, Navis GJ, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203(2):631–7.
Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844–7.
Simmons J, Pittet JF. The coagulopathy of acute sepsis. Curr Opin Anaesthesiol. 2015;28(2):227–36.
Nakamura S, Imamura T, Okamoto K. Tissue factor in neutrophils: Yes. J Thromb Haemost. 2004;2(2):214–7.
Della Valle P, Pavani G, D’Angelo A. The protein C pathway and sepsis. Thromb Res [Internet]. 2012;129(3):296–300. Available from: http://dx.doi.org/10.1016/j. thromres.2011.11.013
Sarkisian L, Saaby L, Poulsen TS, Gerke O, Hosbond S, Jangaard N, et al. Prognostic impact of myocardial injury related to various cardiac and noncardiac conditions. Am J Med [Internet]. 2016;129(5):506-514.e1. Available from: http://dx.doi.org/10.1016/j.amjmed.2015.12.009
Lim W, Qushmaq I, Devereaux PJ, Heels-Ansdell D, Lauzier F, Ismaila AS, et al. Elevated cardiac troponin measurements in critically Ill patients. Arch Intern Med. 2006;166(22):2446–54.
Libby P, Loscalzo J, Ridker PM, Farkouh ME, Hsue PY, Fuster V, et al. Inflammation, immunity, and infection in atherothrombosis: JACC review topic of the week. J Am Coll Cardiol. 2018;72(17):2071–81.
Chapman AR, Shah ASV, Lee KK, Anand A, Francis O, Adamson P, et al. Long-term outcomes in patients with type 2 myocardial infarction and myocardial injury.Circulation. 2018;137(12):1236–45.
Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020;71(15):762–8.
Frey N, Porter D. Cytokine release syndrome with chimeric antigen receptor T cell therapy. Biol Blood Marrow Transplant [Internet]. 2019;25(4):123–7. Available from: https://doi.org/10.1016/j.bbmt.2018.12.756
Hobai IA, Edgecomb J, LaBarge K, Colucci WS. Dysregulation of intracellular calcium transporters in animal models of sepsis-induced cardiomyopathy. Shock.2015;43(1):3–15.
Unduhan
Diterbitkan
Cara Mengutip
Terbitan
Bagian
Lisensi
Hak Cipta (c) 2021 Cermin Dunia Kedokteran
Artikel ini berlisensi Creative Commons Attribution-NonCommercial 4.0 International License.
